Browse > Article
http://dx.doi.org/10.4062/biomolther.2009.17.4.403

Anti-Cancer Effect of the Combination of Thiacremonone and Docetaxel by Inactivation of NF-κB in Human Cancer Cells  

Ban, Jung-Ok (College of Pharmacy, Chungju National University)
Cho, Jin-Suk (College of Pharmacy, Chungju National University)
Hwang, In-Guk (College of Agriculture, Life and Environments Sciences, Chungju National University)
Noh, Jin-Woo (College of Agriculture, Life and Environments Sciences, Chungju National University)
Kim, Wun-Jae (Departments of Urology and Biochemistry (SCB), College of Medicine, Institute for Tumor Research, Chungju National University)
Lee, Ung-Soo (Department of Food and Biotechnology, Chungju National University)
Moon, Dong-Cheul (College of Pharmacy, Chungju National University)
Jeong, Heon-Sang (College of Agriculture, Life and Environments Sciences, Chungju National University)
Lee, Hee-Soon (College of Pharmacy, Chungju National University)
Hwang, Bang-Yeon (College of Pharmacy, Chungju National University)
Jung, Jae-Kyung (College of Pharmacy, Chungju National University)
Han, Sang-Bae (College of Pharmacy, Chungju National University)
Hong, Jin-Tae (College of Pharmacy, Chungju National University)
Publication Information
Biomolecules & Therapeutics / v.17, no.4, 2009 , pp. 403-411 More about this Journal
Abstract
Thiacremonone, the main component isolated from heated garlic (Allium sativum L.), is interested for using as a cancer preventive or therapeutic agent since garlic has been known to be useful plant in the treatment of cancers. Nuclear factor kappaB (NF-${\kappa}B$) is constitutively activated in the prostate cancer and activation of NF-${\kappa}B$ is implicated in drug resistance in cancer cells. Docetaxel, a semisynthetic analog of paclitaxel, is an antineoplastic drug widely used for advanced various cancer. In previous studies, we found that thiacremonone inhibited activation of NF-${\kappa}B$ in cancer cells and marcrophages. In the present study, we investigated whether thiacremonone could increase susceptibility of prostate cancer cells (PC-3 and DU145) to docetaxel via inactivation of NF-${\kappa}B$. We found that the combination treatment of thiacremonone (50 ${\mu}g$/ml) with docetaxel (5 nM) was more effective in the inhibition of prostate cancer cell growth and induction of apoptosis accompanied with the significant inhibition of NF-${\kappa}B$ activity than those by the treatment of thiacremonone or docetaxel alone. It was also found that NF-${\kappa}B$ target gene expression of Bax, caspase-3 and caspase-9 was much more significantly enhanced, but the expression of Bcl-2 was also much more significantly inhibited by the combination treatment. These results indicate that thiacremonone inhibits NF-${\kappa}B$, and enhances the susceptibility of prostate cancer cells to docetaxel. Thus, thiacremonone could be useful as an adjuvant anti-cancer agent.
Keywords
Thiacremonone; Docetaxel; NF-${\kappa}B$; Apoptotic cell death; Prostate cancer;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
Times Cited By Web Of Science : 1  (Related Records In Web of Science)
Times Cited By SCOPUS : 1
연도 인용수 순위
1 Ban, J. O., Yuk, D. Y., Woo, K. S., Kim, T. M., Lee, U. S., Jeong, H. S., Kim, D. J., Chung, Y. B., Hwang, B. Y., Oh, K. W. and Hong, J. T. (2007) Inhibition of cell growth and induction of apoptosis via inactivation of NF-$\kappa$B by a sulfurcompound isolated from garlic in human colon cancer cells. J. Pharmacol. Sci. 104, 374-383.   DOI   ScienceOn
2 Wang, C. Y., Mayo, M. W. and Baldwin, A. S. (1996). TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-${\kappa}B$. Science 274, 784-787.   DOI   ScienceOn
3 Zhang, H., Morisaki, T. and Nakahara, C. (2003). PSK-mediated NF-$\kappa$B inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1. Oncogene 22, 2088-2096.   DOI   ScienceOn
4 Singh, R. P., Tyagi, A. K., Zhao, J. and Agarwal, R. (2002). Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis. Carcinogenesis Lond. 23, 499-510.   DOI   ScienceOn
5 Sporn. M. B. and Suh. N. (2000). Chemoprevention of cancer. Carcinogenesis Lond. 21, 525-530.   DOI   ScienceOn
6 Wang, W. and Cassidy, J. (2003). Constitutive nuclear factorkappa B mRNA, protein overexpression and enhanced DNA-binding activity in thymidylate synthase inhibitorresistant tumour cells. Br. J. Cancer 88, 624-629.   DOI   ScienceOn
7 Pares, A., Planas, R., Torres, M., Caballeria, J., Viver, J. M., Acero, D., Panes, J., Rigau, J., Santos, J. and Rodes, J. (1998). Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J. Hepatol. 28, 615-621.   DOI   ScienceOn
8 Shigemura, K., Arbiser, J. L., Sun, S. Y., Zayzafoon, M., Johnstone, P. A., Fujisawa, M., Gotoh, A., Weksler, B., Zhau, H. E. and Chung, L. W. (2007). Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer 109, 1279-1289.   DOI   ScienceOn
9 Sun, L. C., Luo, J., Mackey, L. V., Fuselier, J. A. and Coy, D. H. (2007). A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3 K/Akt, $\alpha$V$\alpha$3/$\alpha$V$\alpha$5 and MMP-2/-9. Cancer Lett. 246, 157-166.   DOI   ScienceOn
10 Yance, D. R. and Sagar, S. M. (2006). Targeting angiogenesis with integrative cancer therapies. Integr. Cancer Ther. 5, 9-29.   DOI   ScienceOn
11 Sarafraz, M. and Ahmadi, K. (2008). Paraclinical evaluation of side-effects of Taxanes on auditory system. Acta. Otorhinolaryngol. Ital. 28, 239-242.
12 Scifo, C., Milasi, A., Guarnera, A., Sinatra, F. and Renis, M. (2006). Resveratrol and propolis extract: an insight into the morphological and molecular changes induced in DU145 cells. Oncol. Res. 15, 409-421.
13 Uzzo, R. G., Leavis, P. and Hatch, W. (2002). Zinc inhibits nuclear factorkappa B activation and sensitizes prostate cancer cells to cytotoxic agents. Clin. Cancer Res. 8, 3579-3583.
14 Palayoor, S. T., Youmell, M. Y., Calderwood, S. K., Coleman, C. N. and Price, B. D. (1999). Constitutive activation of I$\kappa$ B $\alpha$ and NF-$\kappa$B in prostate cancer cells is inhibited by ibuprofen. Oncogene 18, 7389-7394.   DOI
15 Qadan, L. R., Perez-Stable, C. M., Anderson, C., D'ppolito, G., Herron, A., Howard, G. A. and Roos, B. A. (2001). 2-Methoxyestradiol induces G2-M arrest and apoptosis in prostate cancer. Biochem. Biophys. Res. Commun. 285, 1259-1266.   DOI   ScienceOn
16 Sabayan, B., Foroughinia, F. and Chohedry, A. (2007). A postulated role of garlic organosulfur compounds in prevention of valproic acid hepatotoxicity. Med. Hypotheses. 68, 512-514.   DOI   ScienceOn
17 Shaikh, I. A., Brown, I., Schofield, A. C., Wahle, K. W. and Heys, S. D. (2008). Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway. Prostate 68, 1635-1646.   DOI   ScienceOn
18 Tedesco, K. L., Thor, A. D., Johnson, D. H., Shyr, Y., Blum, K. A., Goldstein, L. J., Gradishar, W. J., Nicholson, B. P., Merkel, D. E., Murrey, D., Edgerton, S. and Sledge, G. W. (2004). Docetaxel combined with trastuzumab is an active regimen in HER-2 3+overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trial. J. Clin. Oncol. 15, 1071-1077.   DOI   ScienceOn
19 Waddick, K. G. and Uckun, F. M. (1999). Innovative treatment programs against cancer: II. Nuclear factor-${\kappa}B$ (NF-${\kappa}B$) as a molecular target. Biochem. Pharmacol. 57, 9-17.   DOI   ScienceOn
20 Millikan, R., Baez, L., Banerjee, T., Wade, J., Edwards, K., Winn, R., Smith, T. L. and Logothetis, C. (2001). Randomized phase 2 trial of ketoconazole and ketoconazole/doxorubicin in androgen independent prostate cancer. Urol. Oncol. 6, 111-115.   DOI   ScienceOn
21 Ojima, I., Kuduk, S. D., Slater, J. C., Gimi, R. H. and Sun, C. M. (1996). Syntheses of new fluorine-containing taxoids by means of ${\beta}$-lactam synthon method. Tetrahedron 52, 209-224.   DOI   ScienceOn
22 Kwon, O. C., Woo, K. S., Kim, T. M., Kim, D. J., Hong, J. T. and Jeong, H. S. (2006). Physicochemical characteristics of garlic (Allium sativum L.) on the high temperature and pressure treatment. Korean J. Food Sci. Technol. 38, 331-336.   과학기술학회마을
23 Hwang, I. K., Woo, K. S., Kim, D. J., Hong, J. T., Hwang, B. Y., Lee, Y. R. and Jeong, H. S. (2007). Isolation and Identification of an Antioxidant Substance from Heated Garlic (Allium sativum L.). Food Sci. Biotechnol. 16, 963-966   과학기술학회마을
24 Ortiz, M. A., Bayon, Y., Lopez-Hernandez, F. J. and Piedrafita, F. J. (2002). Retinoids in combination therapies for the treatment of cancer: mechanisms and perspectives. Drug Resist. Updat. 5, 162-175.   DOI   ScienceOn
25 Rosenberg, J. E., Ryan, C. J., Weinberg, V. K., Smith, D. C., Hussain, M., Beer, T. M., Ryan, C. W., Mathew, P., Pagliaro, L. C., Harzstark, A. L., Sharib, J. and Small, E. J. (2009). Phase I study of ixabepilone, mitoxantrone, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy: a study of the department of defense prostate cancer clinical trials consortium. J. Clin. Oncol. 27, 2772-2778.   DOI   ScienceOn
26 Ryan, D. P., Kulke, M. H., Fuchs, C. S., Grossbard, M. L., Grossman, S. R., Morgan, J. A., Earle, C. C., Shivdasani, R., Kim, H., Mayer, R. J. and Clark, J. W. (2002). A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma. Cancer 94, 97-103.   DOI   ScienceOn
27 Barkett, M. and Gilmore, T. D. (1999). Control of apoptosis by Rel/NF-${\kappa}B$ transcription factors. Oncogene 18, 6910-6924.   DOI
28 Diaz-Rubio, E. (2004). New chemotherapeutic advances in pancreatic, colorectal, and gastric cancers. Oncologist 282-294.   DOI   ScienceOn
29 Dong, Q. G., Sclabas, G. M. and Fujioka, S. (2002). The function of multiple I$\kappa$B: NF-$\kappa$B complexes in the resistance of cancer cells to Taxol-induced apoptosis. Oncogene 21, 6510-6519.   DOI   ScienceOn
30 Nakagawa, H., Tsuta, K., Kiuchi, K., Senzaki, H., Tanaka, K., Hioki, K. and Tsubura, A. (2001). Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis 22, 891-897.   DOI   ScienceOn
31 Howard, E. W., Lee, D. T., Chiu, Y. T., Chua, C. W., Wang, X. and Wong, Y. C. (2008). Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer. Int. J. Cancer 122, 1941-1948.   DOI   ScienceOn
32 Kelloff, G. J. (2000). Perspectives on cancer chemoprevention research and drug development. Adv. Cancer Res. 78, 199-334.   DOI
33 Kim, J. H., Xu, C., Keum, Y. S., Reddy, B., Conney, A. and Kong, A. N. (2006) Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with $\beta$-phenylethyl isothiocyanate and curcumin. Carcinogenesis 27, 475-482.   DOI   ScienceOn
34 Kim, S. M., Lee, S. Y., Yuk, D. Y., Moon, D. C., Choi, S. S., Kim, Y., Han, S. B., Oh, K. W. and Hong, J. T. (2009). Inhibition of NF-$\kappa$B by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Arch. Pharm. Res. 32, 755-765.   DOI   ScienceOn
35 Baker, J., Ajani, J., Scotté, F., Winther, D., Martin, M., Aapro, M. S. and von Minckwitz, G. (2009). Docetaxel-related side effects and their management. Eur. J. Oncol. Nurs. 13, 49-59.   DOI   ScienceOn
36 Chuang, S. E., Yeh, P. Y. and Lu, Y. S. (2002). Basal levels and patterns of anticancer drug-induced activation of nuclear factor- $\kappa$B (NF-$\kappa$B), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. Biochem. Pharmacol. 63, 1709-1716.   DOI   ScienceOn
37 Andrzejewski, T., Deeb, D., Gao, X., Danyluk, A., Arbab, A. S., Dulchavsky, S. A. and Gautam S. C. (2008). Therapeutic efficacy of curcumin/TRAIL combination regimen for hormonerefractory prostate cancer. Oncol. Res. 17, 257-267.   DOI
38 Ban, J. O., Lee, H. S., Jeong, H. S., Song, S., Hwang, B. Y., Moon, D. C., Yoon, D. Y., Han, S. B. and Hong, J. T. (2009). Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-$\kappa$B. Mol. Cancer Res. 7, 870-879.   DOI   ScienceOn